Page 1

Liva Nova Health innovation that matters NEWS RELEASE LivaNova Reports Second Quarter 2021 Results and Appoints Alex Shvartsburg as Chief Financial Officer London , July 28 , 2021 LivaNova PLC ( NASDAQ : LIVN ) , a market - leading medical technology and innovation company , today reported results for the quarter ended June 30 , 2021 . For the second quarter of 2021 , worldwide sales from continuing operations were $ 264.5 million , an increase of 45.2 percent on a reported basis and 41.0 percent on a constant - currency ¹ basis , as compared to the same quarter of the previous year . Worldwide sales from continuing operations for the second quarter of 2021 , excluding sales related to the Heart Valves business that was divested effective June 1 as part of the initial closing , were $ 249.8 million , an increase of 51.6 percent on a reported basis and 47.6 percent on a constant- currency basis , as compared to the same quarter of the previous year . On the basis of U.S. Generally Accepted Accounting Principles ( GAAP ) , second quarter 2021 diluted loss per share from continuing operations was $ 1.13 . Second quarter 2021 adjusted diluted earnings per share from continuing operations was $ 0.52 . " As we navigate shifting market dynamics resulting from the pandemic , we continue to gain momentum in Epilepsy sales growth across all regions , " said Damien McDonald , Chief Executive Officer of LivaNova . " Procedure volumes in Neuromodulation continue to recover , especially replacement implant volumes . Across our businesses , certain countries in our Europe and Rest of World regions remain challenged by COVID - 19 . Looking ahead , we are focused on delivering critical medical devices and therapies to significant patient populations , while managing our core businesses to drive profitability and cash generation . We also remain committed to investing in our pipeline and taking the appropriate actions to position our business for long - term growth . " ¹Constant - currency percent change is a non - GAAP metric . For an explanation of this and other non - GAAP metrics used in this release , please see the section entitled " Use of Non - GAAP Financial Measures . " For reconciliations of certain non - GAAP metrics , please see the tables that accompany the press release . 1